Virax Biolabs (VRAX) Current Deferred Revenue (2023 - 2025)
Virax Biolabs (VRAX) recorded Current Deferred Revenue of $38,250 in fiscal Q4 2023 (quarter ended Mar 31, 2023).
Powered by 
Analysis
Virax Biolabs (VRAX) Current Deferred Revenue (2023 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.99 Bn | 237.02 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 175.01 Bn | 145.44 Bn | 7.27 Bn |
| 3 | Danaher | 164.93 Bn | 148.74 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 151.84 Bn | 131.26 Bn | 1.96 Bn |
| 5 | Medtronic | 119.05 Bn | 84.30 Bn | 6.34 Bn |
| 6 | Stryker | 113.89 Bn | 100.00 Bn | 4.50 Bn |
| 7 | Boston Scientific | 65.37 Bn | 60.13 Bn | 3.85 Bn |
| 8 | Becton Dickinson | 53.36 Bn | 50.51 Bn | 2.32 Bn |
| 9 | Edwards Lifesciences | 50.83 Bn | 34.83 Bn | 1.35 Bn |
| 10 | Virax Biolabs | 536,746.51 | -20.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 66,373.00 |
| Mar 31, 2025 | 52,993.00 |
| Sep 30, 2024 | 48,376.00 |
| Mar 31, 2024 | 47,955.00 |
| Sep 30, 2023 | 49,679.00 |
| Mar 31, 2023 | 38,250.00 |
API Access
Virax Biolabs Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VRAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "VRAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VRAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();